Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor

The detection of alpha-fetoprotein (AFP) in plasma is important in the diagnosis of hepatocellular carcinoma (HCC) in humans. We developed a biosensor to detect AFP in HCC patient plasma and in a phosphate buffer saline (PBS) solution using a graphene field-effect transistor (G-FET). The G-FET was f...

Full description

Bibliographic Details
Main Authors: Dae Hoon Kim, Hong Gi Oh, Woo Hwan Park, Dong Cheol Jeon, Ki Moo Lim, Hyung Jin Kim, Byoung Kuk Jang, Kwang Soup Song
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/18/11/4032
Description
Summary:The detection of alpha-fetoprotein (AFP) in plasma is important in the diagnosis of hepatocellular carcinoma (HCC) in humans. We developed a biosensor to detect AFP in HCC patient plasma and in a phosphate buffer saline (PBS) solution using a graphene field-effect transistor (G-FET). The G-FET was functionalized with 1-pyrenebutyric acid <i>N</i>-hydroxysuccinimide ester (PBASE) for immobilization of an anti-AFP antibody. AFP was detected by assessing the shift in the voltage of the Dirac point (&#916;V<sub>Dirac</sub>) after binding of AFP to the anti-AFP-immobilized G-FET channel surface. This anti-AFP-immobilized G-FET biosensor was able to detect AFP at a concentration of 0.1 ng mL<sup>&#8722;1</sup> in PBS, and the detection sensitivity was 16.91 mV. In HCC patient plasma, the biosensor was able to detect AFP at a concentration of 12.9 ng mL<sup>&#8722;1</sup>, with a detection sensitivity of 5.68 mV. The sensitivity (&#916;V<sub>Dirac</sub>) depended on the concentration of AFP in either PBS or HCC patient plasma. These data suggest that G-FET biosensors could have practical applications in diagnostics.
ISSN:1424-8220